Ys Biopharma Co, Stock Return On Asset
| YSDelisted Stock | 0.48 0.03 5.88% |
YS Biopharma Co, fundamentals help investors to digest information that contributes to YS Biopharma's financial success or failures. It also enables traders to predict the movement of YS Biopharma Stock. The fundamental analysis module provides a way to measure YS Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to YS Biopharma stock.
YS Biopharma |
YS Biopharma Co, Company Return On Asset Analysis
YS Biopharma's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current YS Biopharma Return On Asset | -0.1 |
Most of YS Biopharma's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, YS Biopharma Co, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, YS Biopharma Co, has a Return On Asset of -0.1014. This is 98.84% lower than that of the Biotechnology sector and 99.57% lower than that of the Health Care industry. The return on asset for all United States stocks is 27.57% lower than that of the firm.
YS Biopharma Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses YS Biopharma's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of YS Biopharma could also be used in its relative valuation, which is a method of valuing YS Biopharma by comparing valuation metrics of similar companies.YS Biopharma is currently under evaluation in return on asset category among its peers.
YS Biopharma Fundamentals
| Return On Equity | -0.78 | |||
| Return On Asset | -0.1 | |||
| Profit Margin | (0.67) % | |||
| Operating Margin | (0.49) % | |||
| Current Valuation | 429.47 M | |||
| Shares Outstanding | 188.33 M | |||
| Shares Owned By Insiders | 81.42 % | |||
| Shares Owned By Institutions | 2.85 % | |||
| Number Of Shares Shorted | 38.89 K | |||
| Price To Book | 2.10 X | |||
| Price To Sales | 0.29 X | |||
| Revenue | 687.2 M | |||
| EBITDA | (76.82 M) | |||
| Net Income | (145.48 M) | |||
| Total Debt | 498.63 M | |||
| Book Value Per Share | 5.10 X | |||
| Cash Flow From Operations | (182.47 M) | |||
| Short Ratio | 0.31 X | |||
| Earnings Per Share | (0.56) X | |||
| Target Price | 4.17 | |||
| Number Of Employees | 773 | |||
| Beta | 0.54 | |||
| Market Capitalization | 192.09 M | |||
| Total Asset | 1.72 B | |||
| Retained Earnings | (1.87 B) | |||
| Working Capital | 377.22 M | |||
| Net Asset | 1.72 B |
About YS Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze YS Biopharma Co,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of YS Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of YS Biopharma Co, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in YS Biopharma Stock
If you are still planning to invest in YS Biopharma Co, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the YS Biopharma's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |